SCYNEXIS was launching Brexafemme, a pill treatment for oral treatment designed to eliminate the yeast causing infection in September 2021. Brexafemme is The first modern prescription oral treatment the market. They had not IT strategy and limited Systems and no support IT for a Commercial launch
Implemented a Multi-Years IT strategy and Roadmap, provided support Program Management and Solution/Vendor Evaluation and Selection. Design overall Enterprise IT Architecture and IT Governance and Security. Define IT Budget and set up IT Organization. IT was ready to support the launch on time and on budget. CEO Marco Tagietti provided the following quote “We needed to upgrade substantially our IT infrastructure to support our first product launch but it was a challenge to find a seasoned permanent CIO. As our fractional CIO, Patrick Retif, who already knew our needs from experience, engaged with our business leaders, designed our IT solutions and budget, managed to source and drive IT readiness for a very successful product launch.